SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001424884-14-000063
Filing Date
2014-05-21
Accepted
2014-05-21 16:33:09
Documents
7
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 form10qa.htm 10-Q/A 30351
  Complete submission text file 0001424884-14-000063.txt   2764834

Data Files

Seq Description Document Type Size
2 tpiv-20140331.xml EX-101.INS 538914
3 tpiv-20140331.xsd EX-101.SCH 31833
4 tpiv-20140331_cal.xml EX-101.CAL 14733
5 tpiv-20140331_def.xml EX-101.DEF 12759
6 tpiv-20140331_lab.xml EX-101.LAB 127149
7 tpiv-20140331_pre.xml EX-101.PRE 95147
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: 10-Q/A | Act: 34 | File No.: 000-27239 | Film No.: 14861151
SIC: 2834 Pharmaceutical Preparations